ULTRALIFE CORP - 10-K Summary (Fiscal Year Ended June 30, 2000)
Business Context and Reporting Period
This report covers the fiscal year ended June 30, 2000, for Ultralife Batteries, Inc. (ULBI), a Delaware corporation. The Company develops, manufactures, and markets primary lithium and polymer rechargeable batteries for consumer, industrial, and military applications. Operations are reported across four segments: Primary Batteries, Rechargeable Batteries, Technology Contracts, and Corporate. The Company is headquartered in Newark, New York, with a significant manufacturing and R&D facility in Abingdon, England.
Key Financial Metrics
| Metric | Fiscal 2000 | Fiscal 1999 |
|---|---|---|
| Total Revenues | $24,514,000 | $21,064,000 |
| Cost of Products Sold | $25,512,000 | $19,016,000 |
| Gross Margin | $(998,000) | $2,048,000 |
| Net Loss | $(10,242,000) | $(7,085,000) |
| Net Loss Per Share | $(0.94) | $(0.68) |
| Cash and Securities | $18,639,000 | $23,556,000 |
| Working Capital | $22,537,000 | $28,435,000 |
| Total Debt & Capital Leases | $4,654,000 | $322,000 |
Note: Debt increased significantly in 2000 due to a new $20 million credit facility entered in June 2000, with $4 million outstanding at year-end.
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 16.4% to $24.5 million, driven by a 12% increase in Primary Battery sales (to $21.8 million) and an 82% increase in Technology Contract revenues (to $2.6 million). Rechargeable battery revenues remained negligible at $25,000.
- Margin Compression: The Company reported a gross loss of $998,000 in 2000, compared to a gross profit of $2.0 million in 1999. Cost of goods sold rose to 104% of revenue, primarily due to higher material costs, implementation of lean manufacturing practices, and the absence of $1.5 million in insurance proceeds that reduced costs in 1999.
- Operating Expenses: Selling, general, and administrative (SG&A) expenses increased 19% to $7.4 million, attributed to legal settlement costs and infrastructure build-out for rechargeable battery production. Research and development (R&D) expenses decreased 10% to $5.3 million.
- Non-Operating Items: The Company recorded a $3.1 million gain on the sale of securities (Intermagnetics General Corporation shares), partially offsetting the operating loss. Interest income declined to $909,000 due to lower cash balances.
Outlook, Risks, and Contingencies
- Guidance & Strategy: Management expects operating expenses to increase as production activities expand. The Company is focusing on commercializing advanced polymer rechargeable batteries and expanding primary battery capacity to meet potential legislative demand (e.g., 10-year battery requirements for smoke alarms).
- Liquidity: As of June 30, 2000, the Company held $18.6 million in cash and securities. Management believes this position is sufficient to satisfy estimated cash requirements for at least 12 months.
- Legal Proceedings: A shareholder class-action lawsuit regarding a 1998 stock offering remains pending; the Company believes the claims are without merit. An appeal is pending regarding a dismissed tortious interference claim.
- Environmental Contingency: An environmental assessment at the Newark facility revealed contaminated soil. Estimated remediation costs are approximately $230,000, with a third party agreeing to reimburse 50% of costs. Final costs are uncertain.
- Customer Concentration: One customer (Fyrnetics, Inc.) accounted for approximately 12% of total revenues in fiscal 2000. Loss of this customer would have a material adverse effect.
Investor Verification Checklist
- Rechargeable Commercialization: Verify the timeline and volume production status of the polymer rechargeable batteries, which generated minimal revenue ($25k) despite significant R&D spend.
- Primary Battery Margins: Investigate the sustainability of the negative gross margin in the Primary Batteries segment, which contributed a loss of $1.2 million despite revenue growth.
- Debt Covenants: Review the terms of the new $20 million credit facility, specifically the tangible net worth requirements and interest rate structures.
- Legal Exposure: Monitor the status of the pending shareholder class-action lawsuit and the outcome of the appeal in the tortious interference case.
- Environmental Costs: Confirm the final cost of soil remediation at the Newark facility and the reliability of the third-party reimbursement agreement.